1
|
Fang WQ, Li SP, Zhang CQ, Xu L, Shi M,
Chen MS and Li JQ: Prophylaxis and clinical treatment for surgical
margin recurrence of small primary hepatocellular carcinoma. Ai
Zheng. 24:834–836. 2005.PubMed/NCBI
|
2
|
Zhi X, Lin L, Yang S, Bhuvaneshwar K, Wang
H, Gusev Y, Lee MH, Kallakury B, Shivapurkar N, Cahn K, et al:
βII-spectrin (SPTBN1) suppresses progression of hepatocellular
carcinoma and Wnt signaling by regulation of Wnt inhibitor
kallistatin. Hepatology. 61:598–612. 2015. View Article : Google Scholar : PubMed/NCBI
|
3
|
Wyke JA: Overview-burgeoning promise in
metastasis research. Eur J Cancer. 36:1589–1594. 2000. View Article : Google Scholar : PubMed/NCBI
|
4
|
Liotta LA, Steeg PS and Stetler-Stevenson
WG: Cancer metastasis and angiogenesis: An imbalance of positive
and negative regulation. Cell. 64:327–336. 1991. View Article : Google Scholar : PubMed/NCBI
|
5
|
Chu XY and Chen LB: Cellular adhesive
molecular and the invasion and metastasis of neoplasm. Yixue
Yanjiusheng Xuebao. 13:42–45. 2000.
|
6
|
Li FH: The inhibitory effect of bioactive
peptides on neoplasm metastasis. Kouqiang Hemian Waike Zazhi.
9:231–234. 1999.
|
7
|
Liu LY, Chen ZY and Zhao TH:
Investigations of a peptide with RGD and YIGSR fragments: Synthesis
and its anti-tumor invasion activities. Zhongguo Xinyao Zazhi.
14:729–731. 2005.
|
8
|
Saiki I, Yoneda J, Kobayashi H, Igarashi
Y, Komazawa H, Ishizaki Y, Kato I and Azuma I: Antimetastatic
effect by anti-adhesion therapy with cell-adhesive peptide of
fibronectin in combination with anticancer drugs. Jpn J Cancer Res.
84:326–335. 1993. View Article : Google Scholar : PubMed/NCBI
|
9
|
Liu LY, Chen ZY and Zhao TH: Synthesis of
RGD identical-fork-peptide derivative with inhibitive effecton
adhesiveness of advanced metastatic tumor cells. Zhongguo Xinyao
Zazhi. 15:1661–1663. 2006.
|
10
|
Zhang HQ, Shinohara H, Gu N, Sasaki H and
Sisido M: Cell adhesion inhibition by RGD peptides linked with a
photoisomerizable nonnatural amino acid. J Southeast Univ.
17:22–26. 2001.
|
11
|
Zhao M, Wang C, Jiang X and Pen S:
Synthesis of RGD containing peptides and their bioactivities. Prep
Biochem Biotechnol. 32:363–380. 2002. View Article : Google Scholar : PubMed/NCBI
|
12
|
Cao K, Zhao TH, Chen ZY, Gao W, Yang HS
and Shi B: The invasive capacity of human lung great cellular
xancerous PG cells on reformed basement membrane and inhibition of
synthetic peptides. Zhongliu Fangzhi Yanjiu. 29:20–22. 2002.
|
13
|
Okrój M, Dobrzańska-Paprocka Z, Rolka K
and Bigda J: In vitro and in vivo analyses of the biological
activity of RGD peptides towards Ab Bomirski melanoma. Cell Mol
Biol Lett. 8:873–884. 2003.PubMed/NCBI
|
14
|
Liu J, Guo SX and Tang JG: Research
progress of RGD-peptide for cancer therapy. Guowai Yixue
(Zhongliuxue Fence). 30:193–197. 2003.
|
15
|
Liu YK, Nemoto A, Feng Y and Uemura T: The
binding ability to matrix proteins and the inhibitory effects on
cell adhesion of synthetic peptides derived from a conserved
sequence of integrins. J Biochem. 121:961–968. 1997. View Article : Google Scholar : PubMed/NCBI
|
16
|
Uemura T, Nemoto A and Liu YK: Synthetic
peptide derived from a conserved sequence of integrin β subunit.
Res Adv in Biosci & Bioeng. 23:65–83. 2000.
|
17
|
Sun JJ, Zhou XD, Liu YK, Tang ZY, Sun RX,
Zhao Y and Uemura T: Inhibitory effects of synthetic beta peptide
on invasion and metastasis of liver cancer. J Cancer Res Clin
Oncol. 126:595–600. 2000. View Article : Google Scholar : PubMed/NCBI
|
18
|
Wang SM, Zhu J, Li Y, Pan LF, Zha XL and
Liu YK: Molecular cloning and expression of anti-tumor adhesion
peptide (beta3). Sheng Wu Gong Cheng Xue Bao. 21:558–562. 2005.(In
Chinese). PubMed/NCBI
|
19
|
Knutson JR, Lida J, Fields GB and McCarthy
JB: CD44/chondroitin sulfate proteoglycan and alpha 2beta 1
integrin mediate human melanoma cell migration on type IV collagen
and invasion of basement membranes. Mol Biol Cell. 7:383–396. 1996.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Sun FX, Tang ZY, Lui KD, Ye SL, Xue Q, Gao
DM and Ma ZC: Establishment of a metastatic model of human
hepatocellular carcinoma in nude mice via orthotopic implantation
of histologically intact tissues. Int J Cancer. 66:239–243. 1996.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Syrigos KN and Karayiannakis AJ: Adhesion
molecules as targets for the treatment of neoplastic diseases. Curr
Pharm Des. 12:2849–2861. 2006. View Article : Google Scholar : PubMed/NCBI
|
22
|
Jiang CG and Xu HM: Research and
application of anti-adhesion therapy in cancer metastasis. Guowai
Yixue (Zhongliuxue Fence). 32:31–34. 2005.
|
23
|
Wang YH, Liu YK, Li WC, Ye SL and Tang ZY:
Inhibitory effect of anti-adhesion peptides on invasion/metastasis
ability of hepatocellular carcinoma cells. Zhonghua Shiyan Waike
Zazhi. 21:1168–1169. 2004.
|
24
|
Liu YK, Wu WZ, Wu X, Jiang Y and Zhou XD:
Liver cancer metastasis and signal transduction. In: Tang ZY.
Metastasis and recurrence of hepatocellular carcinoma-basic and
clinical studies. Shanghai Shanghai Scientific and technological
education public house. 93–104. 2003.
|
25
|
Maeda M, Izuno Y, Kawasaki K, Kaneda Y, Mu
Y, Tsutsumi Y, Nakagawa S and Mayumi T: Amino acids and peptides.
XXXI. Preparation of analogs of the laminin-related peptide YIGSR
and their inhibitory effect on experimental metastasis. Chem Pharm
Bull (Tokyo). 46:347–350. 1998. View Article : Google Scholar : PubMed/NCBI
|
26
|
Kaneda Y, Yamamoto Y, Okada N, Tsutsuml Y,
Nakagawa S, Kakiuch M, Maeda M, Kawasaki K and Mayumi T:
Antimetastatic effect of synthetic Glu-Ile-Leu-Asp-Val peptide
derivatives containing D-amino acids. Anticancer Drugs. 8:702–707.
1997. View Article : Google Scholar : PubMed/NCBI
|
27
|
Feng ZH, Huang B, Zhang GM, Li D and Wang
HT: Inducement of antitumor-immunity by DC activated by Hsp70-H22
tumor antigen peptide. Chinese Journal of Cancer Research.
15:79–85. 2003. View Article : Google Scholar
|
28
|
Wang SM, Zhu J, Li Y, Pan LF, Zha XL and
Liu YK: Inhibitory effects of β peptide and polymeric β peptide on
adhesion of hepatocellular carcinoma cells to fibronectin. Shiyong
Zhongliu Zazhi. 21:223–226. 2005.
|
29
|
Li NF, Gemenetzidis E, Marshall FJ, Davies
D, Yu Y, Frese K, Froeling FE, Woolf AK, Feakins RM, Naito Y, et
al: RhoC interacts with integrin α5β1 and enhances its trafficking
in migrating pancreatic carcinoma cells. PLoS One. 8:e815752013.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Sengupta N and MacDonald TT: The role of
matrix metalloproteinases in stromal/epithelial interactions in the
gut. Physiology (Bethesda). 22:401–409. 2007. View Article : Google Scholar : PubMed/NCBI
|
31
|
Benton G, Arnaoutova I, George J, Kleinman
HK and Koblinski J: Matrigel: From discovery and ECM mimicry to
assays and models for cancer research. Adv Drug Deliv Rev 79–80.
3–18. 2014. View Article : Google Scholar
|